Makoto Rheault-KiharainFront Row Ventures BlogBehind the Deal: InVivo AIOur 6th investment uses AI to streamline drug development.Jan 17, 2019Jan 17, 2019
Makoto Rheault-KiharainFront Row Ventures BlogBehind the Deal: PelcroThe thinking behind Front Row Ventures’ first investment.Feb 1, 2018Feb 1, 2018